Stemtech Corp. (STEK) intrinsic value & 10-year financials
Stemtech Corp. (STEK) has a Graham intrinsic value of $0.13 per share. Over the last 10 fiscal years revenue shrank 8.1% a year to $2.9M, with an average return on invested capital of 438.0%.
- Graham intrinsic value
- $0.13
- Share price (Oct 17, 2026)
- $0.00
- Market cap
- $17.0K
- Revenue (FY2025)
- $2.9M
- Revenue growth (10-yr CAGR)
- -8.1%
- ROIC (10-yr avg)
- 438.0%
- Free cash flow (FY2025)
- -$483.6K
STEK 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $2.9M | -$4.0M | -$0.02 | -$483.6K | -94.2% | 136.9% |
| FY2024 | $5.1M | -$3.8M | -$0.03 | -$601.2K | -47.2% | -912.4% |
| FY2023 | $4.9M | -$5.4M | -$0.07 | -$2.0M | -85.8% | 5046.1% |
| FY2022 | $4.6M | -$8.5M | -$0.19 | — | -110.2% | 176.9% |
| FY2021 | $4.3M | -$7.1M | -$0.19 | — | -74.3% | 79.0% |
| FY2020 | $4.4M | -$916.7K | -$0.03 | -$278.3K | -32.7% | -266.0% |
| FY2019 | — | -$33.8K | — | — | — | 19.4% |
| FY2018 | — | -$37.3K | — | — | — | 26.8% |
| FY2017 | — | -$46.3K | — | — | — | 43.3% |
| FY2016 | — | -$28.4K | — | — | — | 30.2% |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Stemtech Corp revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
Stemtech Corp has earned high returns on invested capital, averaging 37.6% ROIC over the available history. High ROIC is consistent with a durable franchise, but it is not by itself proof of an economic moat.
Stemtech Corp capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, Stemtech Corp is modeled at -8.1% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $0.13 per share.